GPR137 and leukemia: It is shown that GPR137 was constitutively expressed in leukemia cells, and through leading cells in G0/G1 phase, its silence inhibited cell proliferation and promoted apoptosis in K562 and HL60 cells, which indicates that targeting GPR137 may serve as a potentially novel approach for the diagnosis and therapy of leukemia.